{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T20:17:34Z","timestamp":1789503454392,"version":"build-2803163510"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,12,20]],"date-time":"2025-12-20T00:00:00Z","timestamp":1766188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T00:00:00Z","timestamp":1769731200000},"content-version":"vor","delay-in-days":41,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Marmara University, School of Medicine Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Pediatr"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>To demonstrate that the CA19-9\/creatinine level could be a potential biomarker in children with obstruction by including ureteropelvic junction obstruction (UPJO) patients and comparing them not only with healthy controls but also with children with non-obstructive hydronephrosis (HN).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Materials and methods<\/jats:title>\n                    <jats:p>Children with HN and healthy controls with no HN were prospectively enrolled into study from March 2021 to December 2022. The children with HN were divided into two separate groups. Group 1 consisted of children with UPJO, while Group 2 included children with lower urinary tract dysfunction (LUTD). Data collected from study and control groups included age, gender, spot urine CA 19\u2009\u2212\u20099\/Cr ratio at the initial visit and at the 6-month follow-up, the Society of Fetal Urology (SFU) grade, antero-posterior (AP) diameter, renal function and diuretic response on mercaptoacetyltriglycine (MAG-3) dynamic renal scintigraphy and surgical or conservative management selection. Spot urine CA 19\u2009\u2212\u20099 levels were measured using the ELISA method.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Out of 283 children, Group 1 consisted of 40 children (11 girls, 29 boys; median age: 7 years), Group 2 comprised 18 children (10 girls, 8 boys; median age:8 years) and 225 healthy controls (83 girls, 142 boys; median age: 8 years). The spot urine CA 19\u2009\u2212\u20099\/Cr ratio was significantly higher in the Group 1 and 2 compared to controls (respectively 86.7, 64.5, 47.1 U\/mg Cr,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.0001). When the two patient groups with HN were compared with each other, no statistically significant difference was observed in the urinary CA19-9\/creatinine levels (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.358). No correlation was found between CA 19\u2009\u2212\u20099\/Cr ratio and HN severity and\/or dynamic renal scintigraphy findings. Surgical management of unilateral UPJO revealed a decrease in CA 19\u2009\u2212\u20099\/Cr in the study group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>This study suggests that the spot urine CA 19\u2009\u2212\u20099\/creatinine ratio may serve as a promising, non-invasive biomarker for distinguishing children with unilateral UPJO and non-obstructive HN from healthy controls. Although elevated levels in patients and postoperative decline were observed, its inability to predict HN severity or the necessity for surgical intervention limits its clinical utility.<\/jats:p>\n                    <jats:p>Keywords: CA19-9, biomarker, ureteropelvic junction obstruction, hydronephrosis, lower urinary tract dysfunction<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1186\/s12887-025-06453-3","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T23:34:42Z","timestamp":1766187282000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Evaluation of spot urine CA 19\u2009\u2212\u20099\/creatinine ratio in diagnosis and management of hydronephrosis in children: a prospective study"],"prefix":"10.1186","volume":"26","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5043-5825","authenticated-orcid":false,"given":"Mehmet Umut","family":"Kutukoglu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9387-250X","authenticated-orcid":false,"given":"Turker","family":"Altuntas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0334-2466","authenticated-orcid":false,"given":"Cagri Akin","family":"Sekerci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5671-9071","authenticated-orcid":false,"given":"Sultan Seval","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4037-283X","authenticated-orcid":false,"given":"Goncagul","family":"Haklar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8275-5479","authenticated-orcid":false,"given":"Kamil","family":"Cam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3387-3524","authenticated-orcid":false,"given":"Tufan","family":"Tarcan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9837-5510","authenticated-orcid":false,"given":"Selcuk","family":"Yucel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,12,20]]},"reference":[{"issue":"9","key":"6453_CR1","doi-asserted-by":"publisher","first-page":"1253","DOI":"10.1007\/s00467-005-1989-3","volume":"20","author":"N Aksu","year":"2005","unstructured":"Aksu N, et al. Postnatal management of infants with antenatally detected hydronephrosis. Pediatr Nephrol. 2005;20(9):1253\u20139.","journal-title":"Pediatr Nephrol"},{"issue":"3 Pt 1","key":"6453_CR2","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1016\/j.juro.2007.05.055","volume":"178","author":"JC Austin","year":"2007","unstructured":"Austin JC, Elliott S, Cooper CS. Patients with spina bifida and bladder cancer: atypical presentation, advanced stage and poor survival. J Urol. 2007;178(3 Pt 1):798\u2013801.","journal-title":"J Urol"},{"issue":"6","key":"6453_CR3","doi-asserted-by":"publisher","first-page":"483","DOI":"10.3109\/1354750X.2012.691553","volume":"17","author":"SM Rappaport","year":"2012","unstructured":"Rappaport SM. Biomarkers intersect with the exposome. Biomarkers. 2012;17(6):483\u20139.","journal-title":"Biomarkers"},{"issue":"2","key":"6453_CR4","first-page":"B4582","volume":"60","author":"MG Madsen","year":"2013","unstructured":"Madsen MG. Urinary biomarkers in hydronephrosis. Dan Med J. 2013;60(2):B4582.","journal-title":"Dan Med J"},{"issue":"1","key":"6453_CR5","doi-asserted-by":"publisher","first-page":"e621","DOI":"10.1016\/j.jpurol.2017.09.012","volume":"14","author":"F Alizadeh","year":"2018","unstructured":"Alizadeh F, Taefnia AM, Haghdani S. Urinary carbohydrate antigen 19\u2009\u2013\u20099\/creatinine ratio: a non-invasive marker for follow-up of unilateral ureteropelvic junction obstruction in children. J Pediatr Urol. 2018;14(1):e621-4.","journal-title":"J Pediatr Urol"},{"issue":"1","key":"6453_CR6","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1159\/000281648","volume":"45","author":"G Ohshio","year":"1990","unstructured":"Ohshio G, et al. Immunohistochemical distribution of CA19-9 in normal and tumor tissues of the kidney. Urol Int. 1990;45(1):1\u20133.","journal-title":"Urol Int"},{"issue":"3","key":"6453_CR7","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1093\/clinchem\/29.3.549","volume":"29","author":"BC Del Villano","year":"1983","unstructured":"Del Villano BC, et al. Radioimmunometric assay for a monoclonal antibody-defined tumor marker, CA 19\u2009\u2013\u20099. Clin Chem. 1983;29(3):549\u201352.","journal-title":"Clin Chem"},{"issue":"3","key":"6453_CR8","doi-asserted-by":"publisher","first-page":"e1331","DOI":"10.1016\/j.jpurol.2014.12.012","volume":"11","author":"A Atar","year":"2015","unstructured":"Atar A, et al. The roles of serum and urinary carbohydrate antigen 19\u2009\u2013\u20099 in the management of patients with antenatal hydronephrosis. J Pediatr Urol. 2015;11(3):e1331\u20135.","journal-title":"J Pediatr Urol"},{"issue":"3","key":"6453_CR9","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s00467-020-04750-w","volume":"36","author":"K Fendereski","year":"2021","unstructured":"Fendereski K, et al. Comparing predictive values of carbohydrate antigen 19\u2009\u2013\u20099, neutrophil gelatinase-associated lipocalin, and kidney injury molecule-1 in 161 patients with ureteropelvic junction obstruction. Pediatr Nephrol. 2021;36(3):631\u20138.","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"6453_CR10","doi-asserted-by":"publisher","first-page":"2353","DOI":"10.1016\/j.juro.2010.02.031","volume":"183","author":"AM Kajbafzadeh","year":"2010","unstructured":"Kajbafzadeh AM, et al. Urinary and serum carbohydrate antigen 19\u2009\u2013\u20099 as a biomarker in ureteropelvic junction obstruction in children. J Urol. 2010;183(6):2353\u201360.","journal-title":"J Urol"},{"issue":"8","key":"6453_CR11","doi-asserted-by":"publisher","first-page":"1650","DOI":"10.1016\/j.jpedsurg.2018.09.007","volume":"54","author":"B Nabavizadeh","year":"2019","unstructured":"Nabavizadeh B, et al. Value of urinary carbohydrate antigen 19\u2009\u2013\u20099 to predict failure of Conservative management in children with ureteropelvic junction obstruction. J Pediatr Surg. 2019;54(8):1650\u20133.","journal-title":"J Pediatr Surg"},{"issue":"6","key":"6453_CR12","doi-asserted-by":"publisher","first-page":"e8441","DOI":"10.1016\/j.jpurol.2020.09.005","volume":"16","author":"\u00dc \u00d6zkuvanc\u0131","year":"2020","unstructured":"\u00d6zkuvanc\u0131 \u00dc, et al. Can urinary biomarkers detect obstruction defined by renal functional loss in antenatal hydronephrosis? J Pediatr Urol. 2020;16(6):e8441\u20137.","journal-title":"J Pediatr Urol"},{"issue":"2","key":"6453_CR13","doi-asserted-by":"publisher","first-page":"104","DOI":"10.4103\/jiaps.jiaps_204_23","volume":"29","author":"S Geminiganesan","year":"2024","unstructured":"Geminiganesan S, et al. Comparison of urinary biomarkers in diagnosis of ureteropelvic junction obstruction and differentiation from nonobstructive dilatation. J Indian Assoc Pediatr Surg. 2024;29(2):104\u20139.","journal-title":"J Indian Assoc Pediatr Surg"},{"issue":"10","key":"6453_CR14","doi-asserted-by":"publisher","first-page":"2277","DOI":"10.1007\/s00467-022-05488-3","volume":"37","author":"G Sangeetha","year":"2022","unstructured":"Sangeetha G, Babu R. Comparing accuracy of urinary biomarkers in differentiation of ureteropelvic junction obstruction from nonobstructive dilatation in children. Pediatr Nephrol. 2022;37(10):2277\u201387.","journal-title":"Pediatr Nephrol"},{"issue":"8","key":"6453_CR15","doi-asserted-by":"publisher","first-page":"162371","DOI":"10.1016\/j.jpedsurg.2025.162371","volume":"60","author":"G Sangeetha","year":"2025","unstructured":"Sangeetha G, et al. Role of urinary biomarkers in the postoperative Follow-Up of ureteropelvic junction obstruction: A preliminary report. J Pediatr Surg. 2025;60(8):162371.","journal-title":"J Pediatr Surg"},{"issue":"5","key":"6453_CR16","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1016\/j.eururo.2023.12.005","volume":"85","author":"M Gnech","year":"2024","unstructured":"Gnech M, et al. Update and summary of the European association of urology\/European society of paediatric urology paediatric guidelines on vesicoureteral reflux in children. Eur Urol. 2024;85(5):433\u201342.","journal-title":"Eur Urol"},{"issue":"6","key":"6453_CR17","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1007\/BF02012459","volume":"23","author":"SK Fernbach","year":"1993","unstructured":"Fernbach SK, Maizels M, Conway JJ. Ultrasound grading of hydronephrosis: introduction to the system used by the society for fetal urology. Pediatr Radiol. 1993;23(6):478\u201380.","journal-title":"Pediatr Radiol"},{"issue":"11","key":"6453_CR18","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrurol.2014.240","volume":"11","author":"F Khan","year":"2014","unstructured":"Khan F, et al. Management of ureteropelvic junction obstruction in adults. Nat Rev Urol. 2014;11(11):629\u201338.","journal-title":"Nat Rev Urol"},{"issue":"10","key":"6453_CR19","doi-asserted-by":"publisher","first-page":"1626","DOI":"10.1080\/0886022X.2016.1202732","volume":"38","author":"E Amini","year":"2016","unstructured":"Amini E, et al. The role of serum and urinary carbohydrate antigen 19\u2009\u2013\u20099 in predicting renal injury associated with ureteral stone. Ren Fail. 2016;38(10):1626\u201332.","journal-title":"Ren Fail"},{"issue":"7","key":"6453_CR20","first-page":"682","volume":"22","author":"EP Miranda","year":"2017","unstructured":"Miranda EP, et al. The role of urinary KIM-1, NGAL, CA19-9 and \u03b22-microglobulin in the assessment of ureteropelvic junction obstruction in adults. Biomarkers. 2017;22(7):682\u20138.","journal-title":"Biomarkers"},{"issue":"4","key":"6453_CR21","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1002\/nau.25382","volume":"43","author":"CA Sekerci","year":"2024","unstructured":"Sekerci CA, Yucel S, Tarcan T. Urinary biomarkers in children with neurogenic and non-neurogenic lower urinary tract dysfunction: a systematic review and meta-analysis. Neurourol Urodyn. 2024;43(4):1003\u201318.","journal-title":"Neurourol Urodyn"}],"container-title":["BMC Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12887-025-06453-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06453-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12887-025-06453-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,1,30]],"date-time":"2026-01-30T13:28:09Z","timestamp":1769779689000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12887-025-06453-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,20]]},"references-count":21,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["6453"],"URL":"https:\/\/doi.org\/10.1186\/s12887-025-06453-3","relation":{},"ISSN":["1471-2431"],"issn-type":[{"value":"1471-2431","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,12,20]]},"assertion":[{"value":"22 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was approved by the Ethics Committee of Marmara University (Approval Number: 09.2021.167). The study was conducted in accordance with the Declaration of Helsinki.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"The parents of the patients provided written informed consent for the publication of clinical data.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"75"}}